| Tag | Content |
|---|
EnhancerAtlas ID | HS141-12120 |
Organism | Homo sapiens |
Tissue/cell | NB4 |
Coordinate | chr21:36847050-36848910 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| HSF1 | MA0486.2 | chr21:36847111-36847124 | GAAACTTCTAGAA | - | 6.25 | | NFAT5 | MA0606.1 | chr21:36847378-36847388 | ATTTTCCATT | + | 6.02 | | NFAT5 | MA0606.1 | chr21:36848192-36848202 | AATGGAAAAT | - | 6.02 | | NFATC1 | MA0624.1 | chr21:36847378-36847388 | ATTTTCCATT | + | 6.02 | | NFATC1 | MA0624.1 | chr21:36848192-36848202 | AATGGAAAAT | - | 6.02 | | NFATC3 | MA0625.1 | chr21:36847378-36847388 | ATTTTCCATT | + | 6.02 | | NFATC3 | MA0625.1 | chr21:36848192-36848202 | AATGGAAAAT | - | 6.02 | | Sox6 | MA0515.1 | chr21:36847383-36847393 | CCATTGTTTT | + | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_25562 | chr21:36841210-36852068 | DND41 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr21 | 36847160 | 36847559 | | chr21 | 36847397 | 36847674 |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH21I035475 | chr21 | 36847790 | 36850156 | | GH21I035476 | chr21 | 36847397 | 36847674 |
|
Enhancer Sequence | AGAAATATGA TGTAAAGAGA GATTTATTTG TATATTATTT CCCTAAGACA GTTTCCTTCT 60
AGAAACTTCT AGAAGTTGAA TGGCTATGCA AAAGTATCTT CTTGTTTCTT AACTTGTATT 120
GCCAGGATGC ATTGCACTGA AAACGGTAAA GTGGAATGAG ATCTCTGCTT TCCTTAGTTA 180
CTCTCAAATT AACAGCTGGT TAACAAAAGC CGTCTTAGGT ATTAGTAGCT CAAAAACCTC 240
TTCTATGTAT TACAAAGCCC TACAACAAGT GAGCCCAGGA GGTCAATGAA AATGCAATGT 300
ATGGACTTTT CCTATCCAGG CAGGGCTCAT TTTCCATTGT TTTATTTCTG AAATGAAGAG 360
CATTTCCAAA GCTGTTTGAG GAAGCTGGGC TGCTTGATGA TTGAAGAGAC ATGTGATGAA 420
CACCCAAGTT CTCCATCTTA GTCACCACAT CAGCATCAGG GATGTGATAA TAGCTGTACT 480
GTCCTAAATG CATACTTTCC AAAGATTGGC CTTGCTTGCT GCTTTCTGGA AAGGAAGTGT 540
CCAATGCATG CCTTTCTTCT TTAGGAAAAA AAAAGCTCCA TTATATGCAG CTTCAGTAAA 600
CATCTCCCTT TGGTTTGATT TCCCACTCTT CAGACAATTA ATTATACTCT TCAGGCTCCT 660
AAGAGTAAAA TCTAAATTCA TTACTTTTTT TTTAAATTTA TGACTTTAAA CAGAAAATTA 720
ATGTTACTGA AATAAACAGA ACTTTAGAAA TCAAGCCAGT AACTGTATCC CACCCACCCC 780
CTACAAAACA AAACACAAAA TTAAAATAGC AAGTCAAACG AAAATTAAAT AGACAAAAAT 840
TAAAAGCCAA AAGTGCCATG TGATTGTGTG TACAGTTTAT CACCCTGTAA AAATCTAGAT 900
GAATTGGTGC AATGCAAATA AAACTTCAAA TAAGTACATC AATTTTAAAA AGAAATGAAT 960
TCCTTTTCCC CCATAAAATT AGAAAGTGAT AGTAGAGAAA ATGAGAAAAT GTTGAAAAGA 1020
TAACAGATGT GTTGGGGTTA TTCTGTTTCA GACTTTACCC AAGAGAAAGC GATTGGAGAA 1080
TTGCCTAATC CTGGTATCAT GTTTCCGGCT ATGACAGGAA GAGATAGATC ATAATAGATA 1140
AAAATGGAAA ATGTTGTGAA AAAATCAAAT ACTTCTAAGA AAGACAAAAC GCAAGACTCA 1200
GCTGTGGTGA GTGTTAAAGG AAATGAGTGT CGCAACTAGA TGAAGCTCAA GACATATATT 1260
TAAACATGTT CTAATGGTGG AACAGTGAGA AGAACAGCTA AGAATAATGG CCTAAGACAG 1320
TCTCAGAAAC CCAGGGCTCA GCCCCTGACT CTTTACCCTC AGTGATTCTC CCCATCAAAC 1380
CCCATGATCT GTCTGGGCAG TCTTATTCTC AACACCTCCC TTGATGGAAG TCTAATCTCA 1440
GCTTCTAGAT ATTCTAACCA GAGGTCTAAG TCAATCCTTT CTGAAATTTA AATTCAATTC 1500
TTTTTTTAAC CTGACTCTCA AGAGAAAAAT TCAGGTACTT TCTATTTCCA ATTCCCTTCT 1560
CTAAACTGAA ACATAATGTA ACTTACTTAC TCTTCTCCCC ATGAAATAGC TTACAACTTT 1620
TTGACCTCTA CCAATGGAAT AACTCTCACA CACATACTCC TATGATCAGG CCTCTGATAA 1680
ATATTCAATT ATGTTTTCCA CTTCTTCCCA GGGAGTTGCC TGCAACAGAA ACTGCAAATG 1740
GCATACGAAA GTTTCCTAAT TAAAAAATAA ACCATATGAG TGATCATCTG CTTAACGTCT 1800
TCCTCCTCAC TAGAATATAG GGTTCATAAC ATCAGAGACC CTGTCTCTCA TTCTTAGCTG 1860
|
